Results 221 to 230 of about 89,235 (310)

Pediatric home‐based central venous access device dressings: Medical liquid adhesive versus standard care to reduce dressing disruption: The STICKY‐kids RCT protocol

open access: yesJournal of Hospital Medicine, Volume 21, Issue 9, Page 1089-1099, September 2026.
Abstract Background Central venous access devices (CVADs) are frequently used in Hospital‐At‐Home models to facilitate prolonged intravenous treatment for children. Premature CVAD dressing disruption is common and contributes to device failure. This protocol describes a trial evaluating the adjunctive use of medical liquid adhesive at the dressing–skin
Tricia M. Kleidon   +5 more
wiley   +1 more source

Characterizing the Safety and Efficacy of Propofol in Critically Ill Pediatric Patients. [PDF]

open access: yesJ Pediatr Pharmacol Ther
Colwell B   +5 more
europepmc   +1 more source

Acute and Chronic Pancreatitis in Mitochondrial Disease: A Systematic Review

open access: yesJIMD Reports, Volume 67, Issue 5, September 2026.
ABSTRACT Mitochondrial disease is a common inherited multisystem neurometabolic disorder. Pancreatic dysfunction is a recognised manifestation, most frequently presenting as mitochondrial diabetes. Although pancreatitis cases have been reported in association with mitochondrial disease, acute and chronic pancreatitis in this context remain poorly ...
Olivia Hahl, Mika H. Martikainen
wiley   +1 more source

SPR‐UPLC‐QTOF/MS‐GNPS‐Guided Discovery of Hypermonol J as a Novel Tumor Necrosis Factor‐Binding Small‐Molecule Lead for Inflammatory Storm Intervention

open access: yesMedComm, Volume 7, Issue 9, September 2026.
SPR‐UPLC‐QTOF/MS‐GNPS‐guided screening identified hypermonol J (HPJ) as a high‐affinity TNF‐binding small molecule. HPJ may stabilize TNF dimers, reduce active trimer formation, and suppress TNFR1/NF‐κB signaling, thereby alleviating inflammatory pathology in psoriasis and acute lung injury models.
Yongqi Li   +11 more
wiley   +1 more source

Carbon Dots in Breast Cancer Theranostics: Structure–Property Relationships, Mechanisms, and Translational Insights

open access: yesMedComm – Oncology, Volume 5, Issue 3, September 2026.
This review provides a comprehensive overview of carbon dot–based technologies for breast cancer diagnosis and therapy, including their toxicity profiles. It outlines how C‐dots function as a versatile platform—serving simultaneously as therapeutic agents, drug‐delivery vehicles, and bioimaging tools. The article also highlights cutting‐edge approaches
Srija Sur, Pegah Varamini
wiley   +1 more source

Heparan sulfate and glycomimetics: Advances in synthesis and biological applications for post‐stroke neurorepair

open access: yesNeuroprotection, Volume 4, Issue 3, Page 213-228, September 2026.
ECM, extracellular matrix; BDNF, brain‐derived neuroptrophic factor; FGF, fibroblast growth factor; VEGF, vascular endothelial growth factor. Abstract Heparan sulfate, a structurally diverse glycosaminoglycan that is abundant in the central nervous system (CNS), orchestrates essential processes fundamental to neural plasticity, neurorepair, and ...
Mozammel H. Bhuiyan   +3 more
wiley   +1 more source

Epicutaneo-caval catheter occlusion in neonates without heparin infusion during parenteral nutrition: A descriptive cohort study. [PDF]

open access: yesJPEN J Parenter Enteral Nutr
D'Andrea V   +6 more
europepmc   +1 more source

Construction of an Appropriate Needs Assessment Indicator System for Venous Access Devices in Patients With Septic Shock Based on Fluid Treatment Characteristics: A Delphi Study

open access: yesNursing Open, Volume 13, Issue 9, September 2026.
ABSTRACT Aim The objective of this study is to determine a consensus on the evaluation criteria for venous access tools appropriate for each stage of septic shock using the Delphi method. Design A Delphi design was utilized. Methods A preliminary evaluation indicator system was developed through a systematic review of clinical guidelines, evidence ...
Chao Yu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy